4.3 Article

Influence of Renal Function and Diet on Acid-Base Status in Chronic Kidney Disease Patients

Journal

JOURNAL OF RENAL NUTRITION
Volume 19, Issue 2, Pages 178-182

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.jrn.2008.08.010

Keywords

-

Funding

  1. Programa Institucional de Bolsas de Iniciacao Cientifica-Conselho Nacional de Desenvolvimento Cientificoe Tecnologico
  2. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior

Ask authors/readers for more resources

Objective: We investigated the influence of potential renal acid load (PRAL) and renal function on the degree of metabolic acidosis in patients with chronic kidney disease (CKD). Design: This was a cross-sectional study. Setting: This study was conducted at the Nephrology Outpatient Division of the Hospital Universitario Clementino Fraga Filho (Rio de Janeiro, Brazil). Patients: Thirty CKD patients undergoing conservative treatment were divided according to plasma HCO3- values into acidotic (HCO3- <= 22 mM, n = 15) and nonacidotic (HCO3- > 22 mM, n = 15). Main Outcome Measure: Biochemical, nutritional, and anthropometric parameters and PRAL were measured. Results: The mean of plasma HCO3- values was 17.7 +/- 2.8 mM in the acidotic group, and 25.1 +/- 2.2 mM in the nonacidotic group. There was no significant difference in mean PRAL values between the acidotic (9.8 +/- 6.4 mEq/ day) and nonacidotic (12.7 +/- 10.0 mEq/day) groups, but there was a significant correlation between plasma HCO3- and creatinine clearance (r = 0.78, P < .0001). Based on the receiver operating characteristic curve, the level of creatinine clearance to begin detection of acidosis was 31.8 mL/min, with a sensitivity and specificity of 86.7%. Conclusion: The acid-base status of this group of CKD patients undergoing conservative treatment was mainly determined by degree of renal insufficiency rather than diet. (C) 2009 by the National Kidney Foundation, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Nutrition & Dietetics

Oral iron supplementation in patients with chronic kidney disease: Can it be harmful to the gut microbiota?

Marcia Ribeiro, Larissa Fonseca, Juliana S. Anjos, Jean C. C. Capo-chichi, Natalia A. Borges, Jerrilynn Burrowes, Denise Mafra

Summary: Patients with chronic kidney disease often experience anemia, with oral or intravenous iron supplementation being the main treatment. Recent studies have shown that oral iron supplementation may disrupt gut microbiota and cause oxidative stress, affecting the composition of intestinal flora.

NUTRITION IN CLINICAL PRACTICE (2022)

Article Urology & Nephrology

Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?

Jean Christ Cedras Capo-Chichi, Natalia Alvarenga Borges, Drielly Cristhiny Mendes de Vargas Reis, Lia S. Nakao, Denise Mafra

Summary: In chronic kidney disease patients undergoing hemodialysis, although levels of uremic toxins such as IS, IAA, and p-CS were elevated, there was no correlation found between uremic toxins plasma levels and anemia parameters. Only in patients with Hb < 11 g/dL, there was a negative correlation between hematocrit and IAA plasma levels.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

Review Food Science & Technology

The magical smell and taste: Can coffee be good to patients with cardiometabolic disease?

Marcia Ribeiro, Livia Alvarenga, Ludmila F. M. F. Cardozo, Julie A. Kemp, Ligia S. Lima, Jonatas S. de Almeida, Viviane de O. Leal, Peter Stenvinkel, Paul G. Shiels, Denise Mafra

Summary: Coffee, a globally consumed beverage, is rich in caffeine, antioxidants, and phenolic compounds. It can modulate the composition of the gut microbiota and mitigate inflammation and oxidative stress. It has beneficial effects on diseases such as depression, diabetes, cardiovascular disease, and obesity.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Review Food Science & Technology

Food for healthier aging: power on your plate

Denise Mafra, Stephanie Ariemu Ugochukwu, Natalia A. Borges, Ludmila F. M. F. Cardozo, Peter Stenvinkel, Paul G. Shiels

Summary: Inflammageing is a persistent low-level inflammatory burden that accompanies age-related dysregulation of the immune system. A healthy diet, containing a balanced amount of macronutrients, vitamins, minerals, and poly(phenols), plays an essential role in mitigating the effects of inflammageing and extending healthspan by modulating the activity of various factors.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Review Nutrition & Dietetics

Anthocyanins-rich interventions on oxidative stress, inflammation and lipid profile in patients undergoing hemodialysis: meta-analysis and meta-regression

Isabelle C. V. S. Martins, Michel G. Maciel, Jose L. M. do Nascimento, Denise Mafra, Alexsandro F. Santos, Camila S. Padilha

Summary: The aim of this systematic review and meta-analysis was to evaluate the effects of anthocyanins-interventions on oxidative stress, inflammation, and lipid profile in patients undergoing hemodialysis. The results showed that anthocyanin intervention can reduce oxidative stress and inflammatory parameters, and improve lipid metabolism by increasing HDL cholesterol levels.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2023)

Article Nutrition & Dietetics

Short Report: Choline plasma levels are related to Nrf2 transcriptional expression in chronic kidney disease?

D. Mafra, L. Cardozo, M. Ribeiro-Alves, P. Bergman, P. G. Shiels, P. Stenvinkel

Summary: This cross-sectional pilot study aimed to investigate the possible relationship between plasma choline levels and transcriptional expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) in patients with chronic kidney disease (CKD). The study found a positive correlation between choline plasma levels and Nrf2 expression.

CLINICAL NUTRITION ESPEN (2022)

Review Nutrition & Dietetics

May polydextrose potentially improve gut health in patients with chronic kidney disease?

D. Mafra, B. A. Baptista, E. Sahiun, S. Abuznada, V. O. Leal, N. A. Borges

Summary: This article discusses the potential benefits of polydextrose on gut health, specifically its impact on constipation, in patients with chronic kidney disease.

CLINICAL NUTRITION ESPEN (2022)

Article Urology & Nephrology

Evaluation of Bach1 mRNA expression in patients with chronic kidney disease: A preliminary study

Denise Mafra, Livia Alvarenga, Marcia Ribeiro, Beatriz G. Baptista, Susane Fanton, Bruna R. Paiva, Liana Trugilho, Julie Ann Kemp, Marcelo Alves-Ribeiro, Ludmila F. M. F. Cardozo

Summary: This study aimed to evaluate the expression of Bach1 mRNA in different treatments for chronic kidney disease (CKD). The results showed that Bach1 mRNA expression was significantly higher in patients undergoing hemodialysis compared to peritoneal dialysis and nondialysis patients. This suggests that Bach1 may be a therapeutic target for regulating inflammation in CKD patients.

HEMODIALYSIS INTERNATIONAL (2023)

Review Food Science & Technology

Consumption of Fish in Chronic Kidney Disease - A Matter of Depth

Denise Mafra, Julie A. Kemp, Viviane de O. Leal, Ludmila Cardozo, Natalia A. Borges, Livia Alvarenga, Karla T. R. Teixeira, Peter Stenvinkel

Summary: Fish is a valuable source of nutrients and intake is associated with reduced cardiovascular risk, but recent studies have shown that it also contains TMAO, a toxin associated with cardiovascular diseases. TMAO levels are increased in patients with CKD, but the effects of a fish-rich diet on TMAO levels and cardiovascular outcomes have not been studied yet. This review explores the pros and cons of a fish-rich diet in CKD patients, an area that requires further research.

MOLECULAR NUTRITION & FOOD RESEARCH (2023)

Review Nutrition & Dietetics

Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities

Karen S. Coutinho-Wolino, Manuela F. S. Melo, Jessica C. Mota, Denise Mafra, Jonas T. Guimaraes, Milena B. Stockler-Pinto

Summary: Gut dysbiosis, a common condition in chronic kidney disease (CKD) patients, can lead to uremic toxin production, inflammation, oxidative stress, and cardiovascular disease. Consuming berry fruits, rich in polyphenols and nutrients, has shown promise in positively influencing the gut microbiota and improving clinical outcomes in CKD. However, more research is needed to understand the mechanisms and determine the optimal amount of berries for these effects. Clinical studies are encouraged to further evaluate the potential benefits of berry fruits in CKD patients.

NUTRITION REVIEWS (2023)

Article Plant Sciences

The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial

Beatriz Germer Baptista, Susane Fanton, Marcia Ribeiro, Ludmila F. M. F. Cardozo, Bruna Regis, Livia Alvarenga, Marcelo Ribeiro-Alves, Andresa A. Berretta, Paul G. Shiels, Denise Mafra

Summary: The study aimed to evaluate the effects of propolis supplementation on inflammatory markers in peritoneal dialysis patients with chronic kidney disease. The results showed that propolis supplementation significantly reduced tumor necrosis factor-alpha levels and had a trend to increase the expression of nuclear factor erythroid-2-related factor 2.

PHYTOMEDICINE (2023)

Review Nutrition & Dietetics

Vitamin K and Hallmarks of Ageing: Focus on Diet and Gut Microbiome

Lu Dai, Denise Mafra, Paul G. Shiels, Tilman M. Hackeng, Peter Stenvinkel, Leon J. Schurgers

Summary: Vitamin K and vitamin K-dependent proteins are associated with age-related diseases. The direct impact of vitamin K on cellular senescence is yet to be proven, but its status reflects the complex interactions between dietary intake, gut microbiome activity, and health. It is proposed to emphasize food quality and explore healthy eating patterns containing vitamin K rather than focusing on a single nutrient for dietary recommendations.

NUTRIENTS (2023)

Review Food Science & Technology

Gut Microbiota Interventions to Retain Residual Kidney Function

Denise Mafra, Julie A. Kemp, Natalia A. Borges, Michelle Wong, Peter Stenvinkel

Summary: Residual kidney function is associated with better quality of life and outcome for patients with chronic kidney disease (CKD), and strategies should be implemented to preserve kidney function. Gut dysbiosis due to increased uremic toxin production and endotoxemia is a major cause of kidney damage, and various strategies, including diet, medications, and faecal transplantation, have been proposed to modulate the gut microbiota in these patients. Modifying gut microbiota composition may mitigate chronic kidney damage and preserve residual kidney function, but the effects of diet on residual kidney function remain limited.

TOXINS (2023)

Review Medicine, General & Internal

Royal jelly: a predictive, preventive and personalised strategy for novel treatment options in non-communicable diseases

Beatriz G. Baptista, Ligia S. Lima, Marcia Ribeiro, Isadora K. Britto, Livia Alvarenga, Julie A. Kemp, Ludmila F. M. F. Cardozo, Andresa A. Berretta, Denise Mafra

Summary: Royal jelly is a bee product rich in bioactive components with therapeutic properties, such as antioxidants and anti-inflammatory compounds. It has been shown to have preventive effects on complications related to non-communicable diseases (NCDs) through its role in reducing inflammation, oxidative stress, and intestinal dysbiosis. Personalized use of royal jelly as a non-pharmacological therapy is recommended.

EPMA JOURNAL (2023)

Review Urology & Nephrology

Cinnamon: an aromatic condiment applicable to chronic kidney disease

Laiis de Souza Gouveia Moreira, Isabela de Souza da Costa Brum, Drielly C. M. de Vargas Reis, Liana Trugilho, Tuany R. Chermut, Marta Esgalhado, Ludmila F. M. F. Cardozo, Peter Stenvinkel, Paul G. Shiels, Denise Mafra

Summary: Cinnamon, a widely used spice and traditional herbal medicine, may have beneficial effects on cardiovascular disease, obesity, and diabetes. However, its effectiveness for chronic kidney disease (CKD) remains uncertain. Bioactive compounds in cinnamon can mitigate common complications in CKD patients, such as oxidative stress, inflammation, hyperglycemia, gut dysbiosis, and dyslipidemia. This narrative review explores the mechanisms by which cinnamon may alleviate CKD complications and its potential role as an additional nutritional strategy for this patient group.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2023)

No Data Available